Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 2/20 | 0.58 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.58 |
| ▸ | MIF | P14174 | 2/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.45 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | LNPEP | Q9UIQ6 | 1/20 | 0.44 |
| ▸ | MDM4 | O15151 | 1/20 | 0.44 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.44 |
| ▸ | NPC1 | O15118 | 1/20 | 0.42 |
| ▸ | RAB9A | P51151 | 1/20 | 0.42 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.41 |
| ▸ | NLRP3 | Q96P20 | 1/20 | 0.41 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.41 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9522073 | 1.00 | ESR1 (0.58) | ESR1ESR2MIFKMT2ANPSR1 | |
| Hydrochloric Acid SCHEMBL9522594 | 0.98 | ESR1 (0.56) | ESR1ESR2MIFKMT2ANPSR1 | |
| Hydrochloric Acid SCHEMBL9522600 | 0.98 | ESR1 (0.56) | ESR1ESR2MIFKMT2ANPSR1 | |
| SCHEMBL31409225 | 0.93 | ESR1 (0.51) | ESR1ESR2MIFKMT2ANPSR1 | |
| Hydrochloric Acid SCHEMBL10531321 | 0.92 | ESR1 (0.50) | ESR1ESR2MIFKMT2ANPSR1 | |
| SCHEMBL4954934 | 0.87 | ESR1 (0.58) | ESR1ESR2MIFKMT2ANPSR1 | |
| SCHEMBL23072695 | 0.85 | ESR1 (0.59) | ESR1ESR2MIFKMT2ANPSR1 | |
| SCHEMBL7273379 | 0.85 | ESR1 (0.59) | ESR1ESR2MIFKMT2ANPSR1 | |
| Hydrochloric Acid SCHEMBL28049650 | 0.83 | ESR1 (0.56) | ESR1ESR2MIFKMT2ANPSR1 | |
| Hydrochloric Acid SCHEMBL17360629 | 0.83 | ESR1 (0.56) | ESR1ESR2MIFKMT2ANPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260115330-A1 | RADIOPAQUE MULTI-ARM POLYMERS FOR MEDICAL APPLICATIONS | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2026-04-30 | — | — | US | disclosed |
| US-20260041799-A1 | HYDROLYSIS-RESISTANT HYDROGELS AND METHODS OF TREATMENT USING SAME | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2026-02-12 | — | — | US | disclosed |
| US-20250295838-A1 | HYDROLYSIS-RESISTANT HYDROGELS AND METHODS OF TREATMENT USING SAME | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2025-09-25 | — | — | US | disclosed |
| EP-4573145-A1 | IODINE LABELED HYDROGELS AND PRECURSORS THEREOF WITH IMPROVED PROPERTIES | Boston Scientific Scimed Inc. (US) | 2025-06-25 | — | — | EP | disclosed |
| EP-4573144-A1 | IODINATED CROSSLINKED HYDROGELS AND METHODS OF FORMING THE SAME | Boston Scientific Scimed Inc. (US) | 2025-06-25 | — | — | EP | disclosed |
| CN-119731240-A | Iodine labeled hydrogels and precursors thereof with improved properties | 波士顿科学医学有限公司 | 2025-03-28 | — | — | CN | disclosed |
| US-20250059237-A1 | METHODS OF FORMING RADIOPAQUE PEPTIDES AND MEDICAL HYDROGELS FORMED THEREFROM | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2025-02-20 | — | — | US | disclosed |
| WO-2024040039-A9 | IODINATED CROSSLINKED HYDROGELS AND METHODS OF FORMING THE SAME | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2024-10-17 | — | — | WO | disclosed |
| US-20240335568-A1 | RADIOPAQUE POLYSACCHARIDE HYDROGELS AND METHODS OF MAKING THE SAME | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2024-10-10 | — | — | US | disclosed |
| US-20240075190-A1 | IODINATED CROSSLINKED HYDROGELS AND METHODS OF FORMING THE SAME | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2024-03-07 | — | — | US | disclosed |
| US-20240076266-A1 | IODINE LABELED HYDROGELS AND PRECURSORS THEREOF WITH IMPROVED PROPERTIES | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2024-03-07 | — | — | US | disclosed |
| WO-2024040039-A1 | IODINATED CROSSLINKED HYDROGELS AND METHODS OF FORMING THE SAME | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2024-02-22 | — | — | WO | disclosed |
| WO-2024040166-A1 | IODINE LABELED HYDROGELS AND PRECURSORS THEREOF WITH IMPROVED PROPERTIES | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2024-02-22 | — | — | WO | disclosed |
| US-5273885-A | Using a polyiodothyronine analog of a phenyl compound containing a hydroxyl group ortho to an iodine | SYNTEX (U.S.A.) INC. (US) | 1993-12-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240076266-A1 | IODINE LABELED HYDROGELS AND PRECURSORS THEREOF WITH IMPROVED PROPERTIES | TPO, FANCI, IGF1R | ESR1 3922/4885ESR2 4305/4885MIF 175/4885 |
| US-20240335568-A1 | RADIOPAQUE POLYSACCHARIDE HYDROGELS AND METHODS OF MAKING THE SAME | CD44, ALG1, CA13 | ESR1 4755/4885ESR2 4661/4885MIF 693/4885 |
| US-20250059237-A1 | METHODS OF FORMING RADIOPAQUE PEPTIDES AND MEDICAL HYDROGELS FORMED THEREFROM | HDGF, IAPP, QRFPR | ESR1 3186/4885ESR2 2292/4885MIF 126/4885 |
| US-20260115330-A1 | RADIOPAQUE MULTI-ARM POLYMERS FOR MEDICAL APPLICATIONS | KLK3, BRDT, BPHL | ESR1 923/4885ESR2 1846/4885MIF 321/4885 |
| US-20260041799-A1 | HYDROLYSIS-RESISTANT HYDROGELS AND METHODS OF TREATMENT USING SAME | PAM, CRYAA, COL1A1 | ESR1 3646/4885ESR2 3732/4885MIF 1747/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.